CPhI Korea

The Indian pharmaceutical market is growing at 15% annually, twice the world market growth rate. While its generics market is growing strong, it is also evolving into a cradle for new drugs. As the global pharma industry looks increasingly towards India for high quality, low cost pharma solutions, the country is one of the strongest emerging markets in the pharma industry. India presents great opportunities for all international pharmaceutical companies to explore and benefit from and CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer.

In less than a decade the event has become South Asia’s leading pharma meeting place, covering every step of the supply chain. It has consistently grown to serve as an exclusive congregation for key players across the pharma sector. The event annually hosts domestic and foreign drug makers, contract service providers and pharma machinery players under one roof, giving them a chance to chart out the future growth plans together.

“India being the hub of Pharma, CPhI India is a great platform for the Pharma manufacturers. I have been visiting CPhI India for the last 5 years and I look forward to my visit every year because the brand exposure at CPhI is vast and this is the biggest event in India. The who’s who of the Pharma industry are there to network at CPhI India.” ~ Souvik Banerjee, Seven Pharma (CPhI & P-MEC India 2018 visitor)

Returning to Greater Noida (close to Delhi) on November 26 – 28, CPhI & P-MEC India 2019 will bring together more than 43,000 attendees and 1,500+ exhibiting companies: more than an exhibition, the event also facilitates finding the right partners with its matchmaking tool, celebrates innovation with the Awards and encourages knowledge gathering and sharing with its Conference